Q BioMed Inc.
company.status.inactiveCIK 1596062fmd_18TBKHQWF8QD4Z3WYHTTWJ7FKYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Dec 01, 2012 to Feb 28, 2023, 38 periods
Latest annual · FY2022
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (3)
- Net income
- (2)
Latest quarter · Q4 FY2022
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (0)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- n/m
- Revenue, 5 yearsFY2017 to FY2022
- n/m
- Net income, 5 yearsFY2017 to FY2022
- n/m
Q BioMed Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $284,352 | $195,597 | +45.4% | 10-K 2023-05-26 · proof |
| Gross profit | -$8,988 | -$51,249 | 10-K 2023-05-26 · proof | |
| Operating income | -$3.4 million | -$7.4 million | 10-K 2023-05-26 · proof | |
| Net income | -$2.1 million | -$8.2 million | 10-K 2023-05-26 · proof | |
| Cash from operating activities | $1.9 million | -$4.3 million | 10-K 2023-05-26 · proof | |
| Total assets | $3.5 million | $809,480 | +334.3% | 10-K 2023-05-26 · proof |
| Total liabilities | $8.1 million | $5.5 million | +48% | 10-K 2023-05-26 · proof |
| Cash and cash equivalents | $344,009 | $344,009 | 0% | 10-Q/A 2023-06-23 · proof |
- What was Q BioMed Inc.'s revenue in fiscal 2022?
- Q BioMed Inc. reported revenue of $284,352 for fiscal 2022 (the year ended Nov 30, 2022), against $195,597 the year before (+45.4%). Source: the 10-K filed with the SEC on May 26, 2023. SEC
- What was Q BioMed Inc.'s gross profit in fiscal 2022?
- Q BioMed Inc. reported gross profit of -$8,988 for fiscal 2022 (the year ended Nov 30, 2022), against -$51,249 the year before. Source: the 10-K filed with the SEC on May 26, 2023. SEC
- What was Q BioMed Inc.'s operating income in fiscal 2022?
- Q BioMed Inc. reported operating income of -$3.4 million for fiscal 2022 (the year ended Nov 30, 2022), against -$7.4 million the year before. Source: the 10-K filed with the SEC on May 26, 2023. SEC
- What was Q BioMed Inc.'s net income in fiscal 2022?
- Q BioMed Inc. reported net income of -$2.1 million for fiscal 2022 (the year ended Nov 30, 2022), against -$8.2 million the year before. Source: the 10-K filed with the SEC on May 26, 2023. SEC
- What was Q BioMed Inc.'s cash from operating activities in fiscal 2022?
- Q BioMed Inc. reported cash from operating activities of $1.9 million for fiscal 2022 (the year ended Nov 30, 2022), against -$4.3 million the year before. Source: the 10-K filed with the SEC on May 26, 2023. SEC
- What are Q BioMed Inc.'s total assets?
- As of Nov 30, 2022, Q BioMed Inc. reported total assets of $3.5 million, against $809,480 a year earlier (+334.3%). Source: the 10-K filed with the SEC on May 26, 2023. SEC
- What are Q BioMed Inc.'s total liabilities?
- As of Nov 30, 2022, Q BioMed Inc. reported total liabilities of $8.1 million, against $5.5 million a year earlier (+48%). Source: the 10-K filed with the SEC on May 26, 2023. SEC
- What are Q BioMed Inc.'s cash and cash equivalents?
- As of Nov 30, 2022, Q BioMed Inc. reported cash and cash equivalents of $344,009, against $344,009 a year earlier (0%). Source: the 10-Q/A filed with the SEC on Jun 23, 2023 (restated). SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1596062&period_type=annual&limit=5"Information only, not investment advice.